قارن الطرق
راجع الطرق التي اخترتها جنبًا إلى جنب؛ الصفوف المختلفة مميَّزة.
| الدوائية الحركية القائمة على الفسيولوجيا× | الارتباط المختبري-الحيوي (In Vitro-In Vivo Correlation)× | |
|---|---|---|
| المجال | علم الأدوية | علم الأدوية |
| العائلة | Process / pipeline | Process / pipeline |
| سنة النشأة≠ | 1997 | 1995 |
| صاحب الطريقة≠ | Ivan Nestorov | Gordon Amidon |
| النوع≠ | predictive modeling | bioavailability prediction |
| المصدر التأسيسي≠ | Nestorov, I. (1997). Sensitivity analysis of pharmacokinetic and pharmacodynamic systems. Journal of Pharmacokinetics and Biopharmaceutics, 25(4), 529-543. link ↗ | Amidon, G. L., Lennernäs, H., Shah, V. P., & Crison, J. R. (1995). A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharmaceutical Research, 12(3), 413-420. DOI ↗ |
| الأسماء البديلة≠ | PBPK, PBPK modeling | IVIVC |
| ذات صلة | 3 | 3 |
| الملخص≠ | PBPK is a mechanistic modeling framework that uses physiological parameters, tissue properties, and drug-specific attributes to predict drug concentration time profiles in the body. Developed rigorously in the 1990s by researchers including Nestorov, PBPK integrates anatomy, biochemistry, and kinetics to enable rational drug development, bridging in vitro data to clinical outcomes. | IVIVC is a mathematical relationship between in vitro and in vivo properties of a drug, developed to predict oral bioavailability from dissolution data. Introduced by Amidon and colleagues in the 1995 Biopharmaceutics Classification System, it bridges laboratory measurements and clinical outcomes to streamline drug development. |
| ScholarGateمجموعة البيانات ↗ |
|
|